Please try another search
For the nine months ended 30 September 2021, ItamarMedical Ltd revenues increased 35% to $38.1M. Net lossincreased from $8M to $18.3M. Revenues reflect an increasein demand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsResearch and Development increase from $4.1M to $9.8M(expense), Selling and Marketing increase of 28% to $22.4M(expense).
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 13.57 | 12.56 | 11.98 | 12.77 |
Gross Profit | 9.21 | 8.94 | 8.01 | 8.84 |
Operating Income | -7.33 | -4.57 | -5.3 | -2.65 |
Net Income | -7.98 | -4.75 | -5.52 | -2.94 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 102.34 | 104.43 | 105.82 | 64.14 |
Total Liabilities | 28.41 | 23.13 | 19.99 | 21.07 |
Total Equity | 73.93 | 81.3 | 85.83 | 43.07 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -13.27 | -9.67 | -4.8 | -8.82 |
Cash From Investing Activities | -31.45 | -31.83 | 0.73 | -32.28 |
Cash From Financing Activities | 45.62 | 45.77 | 46.38 | 35.46 |
Net Change in Cash | 0.98 | 4.3 | 42.2 | -5.45 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review